5,626
Views
103
CrossRef citations to date
0
Altmetric
Review

Precision-cut tissue slices as a tool to predict metabolism of novel drugs

, &
Pages 879-898 | Published online: 21 Nov 2007

Bibliography

  • WARBURG O: Versuche an Überlebendem Karzinomgewebe. Biochem. Z (1923) 142:317-333.
  • KREBS HA: Untersuchungen Über den Stoffwechsel der AminosÄuren im TierkÖrper. Hoppe Seyl Z (1933) 217:190-227.
  • OLINGA P, MEIJER DKF, SLOOFF MJH, GROOTHUIS GMM: Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue. Toxicol. In Vitro (1998) 12(1):77-100.
  • BERRY MN, FRIEND DS: High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J. Cell Biol. (1969) 43(3):506-520.
  • KRUMDIECK CL, DOS SANTOS JE, HO KJ: A new instrument for the rapid preparation of tissue slices. Anal. Biochem. (1980) 104:118-123.
  • VICKERS AE, CONNORS S, ZOLLINGER M et al.: The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance. Drug Metab. Dispos. (1993) 21(3):454-459.
  • DE KANTER R, MONSHOUWER M, MEIJER DK, GROOTHUIS GM: Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues. Curr. Drug Metab. (2002) 3(1):39-59.
  • DE KANTER R, DE JAGER MH, DRAAISMA AL et al.: Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices. Xenobiotica (2002) 32(5):349-362.
  • DE KANTER R, MONSHOUWER M, DRAAISMA AL et al.: Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon. Xenobiotica (2004) 34(3):229-241.
  • MARTIGNONI M, DE KANTER R, GROSSI P et al.: An in vivo and in vitro comparison of CYP induction in rat liver and intestine using slices and quantitative RT-PCR. Chem. Biol. Interact. (2004) 151(1):1-11.
  • MARTIGNONI M, MONSHOUWER M, DE KANTER R et al.: Phase I and phase II metabolic activities are retained in liver slices from mouse, rat, dog, monkey and human after cryopreservation. Toxicol. In Vitro (2004) 18(1):121-128.
  • DE KANTER R, TUIN A, VAN DE KERKHOF E et al.: A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies. J. Pharmacol. Toxicol. Methods (2005) 51(1):65-72.
  • VAN DE KERKHOF EG, DE GRAAF IA, DE JAGER MH, MEIJER DK, GROOTHUIS GM: Characterization of rat small intestinal and colon precision-cut slices as an in vitro system for drug metabolism and induction studies. Drug Metab. Dispos. (2005) 33(11):1613-1620.
  • VAN DE KERKHOF EG, UNGELL AL, SJOBERG AK et al.: Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations. Drug Metab. Dispos. (2006) 34(11):1893-1902.
  • VAN DE KERKHOF EG, DE GRAAF IA, DE JAGER MH, GROOTHUIS GM: Induction of phase I and II drug metabolism in rat small intestine and colon in vitro. Drug Metab. Dispos. (2007) 35(6):898-907.
  • VITTORELLI A, GAUTHIER C, MICHOUDET C, BAVEREL G: Metabolic viability and pharmaco-toxicological reactivity of cryopreserved human precision-cut renal cortical slices. Toxicol. In Vitro (2004) 18(3):285-292.
  • VICKERS AE, FISHER RL: Precision-cut organ slices to investigate target organ injury. Expert Opin. Drug Metab. Toxicol. (2005) 1(4):687-699.
  • DE GRAAF IA, DRAAISMA AL, SCHOEMAN O et al.: Cryopreservation of rat precision-cut liver and kidney slices by rapid freezing and vitrification. Cryobiology (2007) 54(1):1-12.
  • FREEMAN BA, O'NEIL JJ: Tissue slices in the study of lung metabolism and toxicology. Environ. Health Perspect. (1984) 56:51-60.
  • FISHER RL, SMITH MS, HASAL SJ et al.: The use of human lung slices in toxicology. Hum. Exp. Toxicol. (1994) 13(7):466-471.
  • PRICE RJ, RENWICK AB, BEAMAND JA et al.: Comparison of the metabolism of 7-ethoxycoumarin and coumarin in precision-cut rat liver and lung slices. Food Chem. Toxicol. (1995) 33(3):233-237.
  • DE GRAAF IA, VAN MEIJEREN CE, PEKTAS F, KOSTER HJ: Comparison of in vitro preparations for semi-quantitative prediction of in vivo drug metabolism. Drug Metab. Dispos. (2002) 30(10):1129-1136.
  • MORENO L, PEREZ-VIZCAINO F, HARRINGTON L et al.: Pharmacology of airways and vessels in lung slices in situ: role of endogenous dilator hormones. Respir. Res. (2006) 7:111.
  • HARRIGAN JA, MCGARRIGLE BP, SUTTER TR, OLSON JR: Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Toxicol. In Vitro (2006) 20(4):426-438.
  • NAVE R, FISHER R, ZECH K: In vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices. Biopharm. Drug Dispos. (2006) 27(4):197-207.
  • DE GRAAF IA, DE KANTER R, DE JAGER MH et al.: Empirical validation of a rat in vitro organ slice model as a tool for in vivo clearance prediction. Drug Metab. Dispos. (2006) 34(4):591-599.
  • PAI KS, RAVINDRANATH V: Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices. Brain Res. (1991) 555(2):239-244.
  • BULL DA, REID BB, CONNORS RC et al.: Improved biochemical preservation of heart slices during cold storage. Int. J. Surg. Investig. (2000) 2(2):117-123.
  • PARRISH AR, GANDOLFI AJ, BRENDEL K: Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci. (1995) 57(21):1887-1901.
  • PARRISH AR, SALLAM K, NYMAN DW et al.: Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology. Cell Biol. Toxicol. (2002) 18(3):205-219.
  • HOFFMANN P, SKIBINSKI G, JAMES K: Organ culture of human lymphoid tissue. I. Characteristics of the system. J. Immunol. Methods (1995) 179(1):37-49.
  • JAMES K, SKIBINSKI G, HOFFMAN P: A comparison of the performance in vitro of precision cut tissue slices and suspensions of human spleen with special reference to immunoglobulin and cytokine production. Hum. Antibodies Hybridomas (1996) 7(4):138-150.
  • BACH PH, VICKERS AEM, FISHER R et al.: The use of tissue slices for pharmacotoxicology studies – the report and recommendations of ECVAM workshop 20. ATLA Altern. Lab. Anim. (1996) 24(6):893-923.
  • EKINS S: Vitrification of precision-cut rat liver slices. Cryo Lett. (1996) 17:7-14.
  • LERCHE-LANGRAND C, TOUTAIN HJ: Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology (2000) 153(1-3):221-253.
  • STEENSMA A, BEAMAND JA, WALTERS DG, PRICE RJ, LAKE BG: Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, cynomolgus monkey and human precision-cut liver slices. Xenobiotica (1994) 24(9):893-907.
  • HOFMANN AF, ZAKKO SF, LIRA M et al.: Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology (2005) 42(6):1391-1398.
  • VERMEIR M, ANNAERT P, MAMIDI RN et al.: Cell-based models to study hepatic drug metabolism and enzyme induction in humans. Expert Opin. Drug Metab. Toxicol. (2005) 1(1):75-90.
  • RESSMEYER AR, LARSSON AK, VOLLMER E et al.: Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur. Respir. J. (2006) 28(3):603-611.
  • ROTS MG, ELFERINK MG, GOMMANS WM et al.: An ex vivo human model system to evaluate specificity of replicating and non-replicating gene therapy agents. J. Gene Med. (2006) 8(1):35-41.
  • VAN DE BOVENKAMP M, GROOTHUIS GM, MEIJER DK, SLOOFF MJ, OLINGA P: Human liver slices as an in vitro model to study toxicity-induced hepatic stellate cell activation in a multicellular milieu. Chem. Biol. Interact. (2006) 162(1):62-69.
  • GUYOT C, COMBE C, BALABAUD C, BIOULAC-SAGE P, DESMOULIERE A: Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J. Hepatol. (2007) 46(1):142-150.
  • JUNG D, ELFERINK MG, STELLAARD F, GROOTHUIS GM: Analysis of bile acid-induced regulation of FXR target genes in human liver slices. Liver Int. (2007) 27(1):137-144.
  • VAN DE BOVENKAMP M, GROOTHUIS GM, MEIJER DK, OLINGA P: Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro. J. Hepatol. (2006) 45(5):696-703.
  • VAN DE BOVENKAMP M, GROOTHUIS GM, MEIJER DK, OLINGA P: Liver fibrosis in vitro: cell culture models and precision-cut liver slices. Toxicol. In Vitro (2007) 21(4):545-557.
  • GUO Y, WANG H, ZHANG C: Establishment of rat precision-cut fibrotic liver slice technique and its application in verapamil metabolism. Clin. Exp. Pharmacol. Physiol. (2007) 34(5-6):406-413.
  • STOFF-KHALILI MA, STOFF A, RIVERA AA et al.: Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system. Breast Cancer Res. (2005) 7(6):R1141-R1152.
  • BRAUN A, TSCHERNIG T: Animal models of asthma: innovative methods of lung research and new pharmacological targets. Exp. Toxicol. Pathol. (2006) 57(Suppl. 2):3-4.
  • VICKERS AE, SAULNIER M, CRUZ E et al.: Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis. Toxicol. Sci. (2004) 82(2):534-544.
  • TOUTAIN HJ, SARSAT JP, BOUANT A et al.: Precision-cut dog renal cortical slices in dynamic organ culture for the study of cisplatin nephrotoxicity. Cell Biol. Toxicol. (1996) 12(4-6):289-298.
  • VICKERS AEM: In vitro systems for predicting rates and routes of drug metabolism in preclinical drug development. European Symposium on the Prediction of Drug Metabolism in Man: Progress and Problems. Liege, Belgium (1998).
  • OLINGA P, MEREMA M, HOF IH et al.: Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab. Dispos. (1998) 26(1):5-11.
  • STEFANIAK MS, KRUMDIECK CL, SPALL RD, GANDOLFI AJ, BRENDEL K: Biochemical and histological characterization of agar-filled precision cut rat lung slices in dynamic organ culture as an in vitro tool. Toxicol. In Vitro (1992) 5:7-19.
  • PRICE RJ, BALL SE, RENWICK AB et al.: Use of precision-cut rat liver slices for studies of xenobiotic metabolism and toxicity: comparison of the Krumdieck and Brendel tissue slicers. Xenobiotica (1998) 28(4):361-371.
  • OLINGA P, GROEN K, HOF IH et al.: Comparison of five incubation systems for rat liver slices using functional and viability parameters. J. Pharmacol. Toxicol. Methods (1997) 38(2):59-69.
  • FISHER RL, ULREICH JB, NAKAZATO PZ, BRENDEL K: Histological and biochemical evaluation of precision-cut liver slices. Toxicol. Methods (2001) 11(2):59-79.
  • OLINGA P, HOF IH, MEREMA MT et al.: The applicability of rat and human liver slices to the study of mechanisms of hepatic drug uptake. J. Pharmacol. Toxicol. Methods (2001) 45(1):55-63.
  • VIETMEIER J, NIEDORF F, BAUMER W et al.: Reactivity of equine airways – a study on precision-cut lung slices. Vet. Res. Commun. (2007) 31(5):611-619.
  • UMACHANDRAN M, HOWARTH J, IOANNIDES C: Metabolic and structural viability of precision-cut rat lung slices in culture. Xenobiotica (2004) 34(8):771-780.
  • SMITH PF, GANDOLFI AJ, KRUMDIECK CL et al.: Dynamic organ culture of precision liver slices for in vitro toxicology. Life Sci. (1985) 36(14):1367-1375.
  • DOGTEROM P: Development of a simple incubation system for metabolism studies with precision-cut liver slices. Drug Metab. Dispos. (1993) 21(4):699-704.
  • VICKERS AEM, FISHER RL: Organ slices for the evaluation of human drug toxicity. Chem. Biol. Interact. (2004) 150(1):87-96.
  • SCHUMACHER K, KHONG YM, CHANG S et al.: Perfusion culture improves the maintenance of cultured liver tissue slices. Tissue Eng. (2007) 13(1):197-205.
  • FISHER RL, HASAL SJ, SANUIK JT et al.: Cold- and cryopreservation of dog liver and kidney slices. Cryobiology (1996) 33(1):163-171.
  • VICKERS AEM: Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals. Cell Biol. Toxicol. (1994) 10(5-6):407-414.
  • HASHEMI E, TILL C, IOANNIDES C: Stability of cytochrome P450 proteins in cultured precision-cut rat liver slices. Toxicology (2000) 149(2-3):51-61.
  • HASHEMI E, DOBROTA M, TILL C, IOANNIDES C: Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures. Xenobiotica (1999) 29(1):11-25.
  • VICKERS AE, FISHER R, OLINGA P: Human liver and kidney slice viability is extended and pathways of fibrosis are characterized. Toxicologist (2005) 84:1914.
  • AMIN K, IP C, SATO B et al.: Characterization of ANIT-induced toxicity using precision-cut rat and dog liver slices cultured in a dynamic organ roller system. Toxicol. Pathol. (2006) 34(6):776-784.
  • UMACHANDRAN M, IOANNIDES C: Stability of cytochromes P450 and phase II conjugation systems in precision-cut rat lung slices cultured up to 72 h. Toxicology (2006) 224(1-2):14-21.
  • MARTIN H, SARSAT JP, LERCHE-LANGRAND C et al.: Morphological and biochemical integrity of human liver slices in long-term culture: effects of oxygen tension. Cell Biol. Toxicol. (2002) 18(2):73-85.
  • 'T HART NA, VAN DER PLAATS A, FABER A et al.: Oxygenation during hypothermic rat liver preservation: an in vitro slice study to demonstrate beneficial or toxic oxygenation effects. Liver Transplant. (2005) 11(11):1403-1411.
  • VANHULLE VP, MARTIAT GA, BONTEMPS F et al.: Cryopreservation of rat precision-cut liver slices is associated with major metabolic stress and ionic perturbations. Cell Physiol. Biochem. (2003) 13(2):103-112.
  • TOUTAIN HJ, MORONVALLE-HALLEY V, SARSAT JP et al.: Morphological and functional integrity of precision-cut rat liver slices in rotating organ culture and multiwell plate culture: effects of oxygen tension. Cell Biol. Toxicol. (1998) 14(3):175-190.
  • FISHER RL, HASAL SJ, SANUIK JT, GANDOLFI AJ, BRENDEL K: Determination of optimal incubation media and suitable slice diameters in precision-cut liver slices – optimization of tissue slice culture. 2. Toxicol. Methods (1995) 5(2):115-130.
  • FISHER RL, SHAUGHNESSY RP, JENKINS PM et al.: Dynamic organ-culture is superior to multiwell plate culture for maintaining precision-cut tissue-slices – optimization of tissue slice culture. 1. Toxicol. Methods (1995) 5(2):99-113.
  • VAN DE BOVENKAMP M, GROOTHUIS GM, DRAAISMA AL et al.: Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. Toxicol. Sci. (2005) 85(1):632-638.
  • OLINGA P, MEREMA MT, DE JAGER MH et al.: Rat liver slices as a tool to study LPS-induced inflammatory response in the liver. J. Hepatol. (2001) 35(2):187-194.
  • SHERRATT AJ, DAMANI LA: Activities of cytosolic and microsomal drug oxidases of rat hepatocytes in primary culture. Drug Metab. Dispos. (1989) 17(1):20-25.
  • BAYLISS MK, BELL JA, WILSON K, PARK GR: 7-Ethoxycoumarin O-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions. Xenobiotica (1994) 24(3):231-241.
  • ROGIERS V, VANDENBERGHE Y, CALLAERTS A et al.: Phase I and phase II xenobiotic biotransformation in cultures and co-cultures of adult rat hepatocytes. Biochem. Pharmacol. (1990) 40(8):1701-1706.
  • WORTELBOER HM, DE KRUIF CA, VAN IERSEL AA et al.: The isoenzyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers. Biochem. Pharmacol. (1990) 40(11):2525-2534.
  • MCMILLAN JM, SHADDOCK JG, CASCIANO DA, ARLOTTO MP, LEAKEY JE: Differential stability of drug-metabolizing enzyme activities in primary rat hepatocytes, cultured in the absence or presence of dexamethasone. Mutat. Res. (1991) 249(1):81-92.
  • RODRIGUEZ-ANTONA C, DONATO MT, BOOBIS A et al.: Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica (2002) 32(6):505-520.
  • LOPEZ-GARCIA MP: Endogenous nitric oxide is responsible for the early loss of P450 in cultured rat hepatocytes. FEBS Lett. (1998) 438(3):145-149.
  • DUNN JC, YARMUSH ML, KOEBE HG, TOMPKINS RG: Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J. (1989) 3(2):174-177.
  • EVANS PJ: Maintenance of cytochrome P-450 levels in hepatocytes preserved on gelatin gels. Cell Biol. Int. (1995) 19(10):855-860.
  • KERN A, BADER A, PICHLMAYR R, SEWING KF: Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem. Pharmacol. (1997) 54(7):761-772.
  • KOEBE HG, PAHERNIK S, EYER P, SCHILDBERG FW: Collagen gel immobilization: a useful cell culture technique for long-term metabolic studies on human hepatocytes. Xenobiotica (1994) 24(2):95-107.
  • MARTIN H, SARSAT JP, DE WAZIERS I et al.: Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices. Pharm. Res. (2003) 20(4):557-568.
  • WRIGHT MC, PAINE AJ: Evidence that the loss of rat liver cytochrome P450 in vitro is not solely associated with the use of collagenase, the loss of cell-cell contacts and/or the absence of an extracellular matrix. Biochem. Pharmacol. (1992) 43(2):237-243.
  • BOESS F, KAMBER M, ROMER S et al.: Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. (2003) 73(2):386-402.
  • VANDENBRANDEN M, WRIGHTON SA, EKINS S et al.: Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices. Drug Metab. Dispos. (1998) 26(11):1063-1068.
  • RENWICK AB, WATTS PS, EDWARDS RJ et al.: Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab. Dispos. (2000) 28(10):1202-1209.
  • PERSSON KP, EKEHED S, OTTER C et al.: Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans. Pharm. Res. (2006) 23(1):56-69.
  • LUPP A, DANZ M, MULLER D: Morphology and cytochrome P450 isoforms expression in precision-cut rat liver slices. Toxicology (2001) 161(1-2):53-66.
  • STEWARD AR, DANNAN GA, GUZELIAN PS, GUENGERICH FP: Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes. Mol. Pharmacol. (1985) 27(1):125-132.
  • PAINE AJ: The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system. Chem. Biol. Interact. (1990) 74(1-2):1-31.
  • DE GRAAF IA, TAJIMA O, GROTEN JP, WOLTERBEEK AP: Intercellular communication and cell proliferation in precision-cut rat liver slices: effect of medium composition and DDT. Cancer Lett. (2000) 154(1):53-62.
  • TRAUB O, DRUGE PM, WILLECKE K: Degradation and resynthesis of gap junction protein in plasma membranes of regenerating liver after partial hepatectomy or cholestasis. Proc. Natl. Acad. Sci. USA (1983) 80(3):755-759.
  • AUBRECHT J, HIRSCH-ERNST KI, FOTH H, KAHL GF, HOHNE MW: Differential induction of mRNA expression of cytochromes P450 (CYP2B1 and CYP1A1/2) by metyrapone in primary rat hepatocyte cultures. Res. Commun. Mol. Pathol. Pharmacol. (1996) 94(1):47-61.
  • KIENHUIS AS, WORTELBOER HM, MAAS WJ et al.: A sandwich-cultured rat hepatocyte system with increased metabolic competence evaluated by gene expression profiling. Toxicol. In Vitro (2007) 21(5):892-901.
  • ELIASSON E, JOHANSSON I, INGELMAN-SUNDBERG M: Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation. Proc. Natl. Acad. Sci. USA (1990) 87(8):3225-3229.
  • PANOUTSOPOULOS GI, BEEDHAM C: Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes. Acta Biochim. Pol. (2004) 51(3):649-663.
  • RODRIGUES AD, FERRERO JL, AMANN MT et al.: The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans. Drug Metab. Dispos. (1994) 22(5):788-798.
  • PISSOWOTZKI K, GLOCKNER R, MULLER D: Glucuronidation of 4-methylumbelliferone and 4-hydroxybiphenyl and in vitro induction of UDP-glucuronosyltransferase 2B12-mRNA in precision-cut rat liver slices. Exp. Toxicol. Pathol. (2003) 54(5-6):489-492.
  • GUNAWARDHANA L, BARR J, WEIR AJ, BRENDEL K, SIPES IG: The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture. Drug Metab. Dispos. (1991) 19(3):648-654.
  • ZENSER TV, LAKSHMI VM, RUSTAN TD et al.: Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res. (1996) 56(17):3941-3947.
  • WILSON VG, GROHMANN M, TRENDELENBURG U: The uptake and O-methylation of 3H-(+/-)-isoprenaline in rat cerebral cortex slices. Naunyn Schmiedebergs Arch. Pharmacol. (1988) 337(4):397-405.
  • WORBOYS PD, BRADBURY A, HOUSTON JB: Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate. Drug Metab. Dispos. (1997) 25(4):460-467.
  • BELJAARS L, OLINGA P, MOLEMA G et al.: Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA). Liver (2001) 21(5):320-328.
  • GONZALO T, BELJAARS L, VAN DE BOVENKAMP M et al.: Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells. J. Pharmacol. Exp. Ther. (2007) 321(3):856-865.
  • HAGENS WI, OLINGA P, MEIJER DK et al.: Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver Int. (2006) 26(2):232-239.
  • MELGERT BN, OLINGA P, JACK VK et al.: Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells. J. Hepatol. (2000) 32(4):603-611.
  • ELFERINK MG, OLINGA P, DRAAISMA AL et al.: LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. (2004) 287(5):G1008-G1016.
  • BORLAK J, KLUTCKA T: Expression of basolateral and canalicular transporters in rat liver and cultures of primary hepatocytes. Xenobiotica (2004) 34(11-12):935-947.
  • RIPPIN SJ, HAGENBUCH B, MEIER PJ, STIEGER B: Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology (2001) 33(4):776-782.
  • TURNCLIFF RZ, TIAN X, BROUWER KL: Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochem. Pharmacol. (2006) 71(10):1520-1529.
  • BARTH A, BRAUN J, MULLER D: Bile acid transport and metabolism in rat liver slices. Exp. Toxicol. Pathol. (2006) 57(4):313-319.
  • BARTH A, BRAUN J, MULLER D: Influence of verapamil and cyclosporin A on bile acid metabolism and transport in rat liver slices. Exp. Toxicol. Pathol. (2006) 58(1):31-37.
  • THOMPSON MB, DAVIS DG, MORRIS RW: Taurine conjugate of 3α,6β,7β-trihydroxy-5β,22-cholen-24-oic acid (tauro-Δ22-β-muricholate): the major bile acid in the serum of female rats treated with α-naphthylisothiocyanate and its secretion by liver slices. J. Lipid Res. (1993) 34(4):553-561.
  • M'BEMBA MEKA P, CHAKRABARTI SK: Effects of different nickel compounds on the transport of p-aminohippurate ion by rat renal cortical slices. Toxicol. Lett. (2001) 122(3):235-244.
  • MAHIEU ST, GIONOTTI M, MILLEN N, ELIAS MM: Effect of chronic accumulation of aluminum on renal function, cortical renal oxidative stress and cortical renal organic anion transport in rats. Arch. Toxicol. (2003) 77(11):605-612.
  • NOZAKI Y, KUSUHARA H, KONDO T et al.: Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J. Pharmacol. Exp. Ther. (2007) 322(3):1162-1170.
  • NOZAKI Y, KUSUHARA H, KONDO T et al.: Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices. J. Pharmacol. Exp. Ther. (2007) 321(1):362-369.
  • MATSUZAKI T, WATANABE H, YOSHITOME K et al.: Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute [corrected] renal failure. Kidney Int. (2007) 71(6):539-547.
  • MATSUMOTO SI, YOSHIDA K, ISHIGURO N, MAEDA T, TAMAI I: Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride]. J. Pharmacol. Exp. Ther. (2007) 322(3):1246-1252.
  • ISHIGURO N, SAITO A, YOKOYAMA K et al.: Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. Drug Metab. Dispos. (2005) 33(4):495-499.
  • CRLJEN V, SABOLIC I, SUSAC J et al.: Immunocytochemical characterization of the incubated rat renal cortical slices. Pflugers Arch. (2005) 450(4):269-279.
  • FISHER RL, SANUIK JT, GANDOLFI AJ, BRENDEL K: Toxicity of cisplatin and mercuric-chloride in human kidney cortical slices. Hum. Exp. Toxicol. (1994) 13(8):517-523.
  • WOLFGANG GHI, GANDOLFI AJ, STEVENS JL, BRENDEL K: N-acetyl S-(1,2-dichlorovinyl)-L-cysteine produces a similar toxicity to S-(1,2-dichlorovinyl)-L-cysteine in rabbit renal slices - differential transport and metabolism. Toxicol. Appl. Pharmacol. (1989) 101(2):205-219.
  • FISHER RL, HASAL SJ, SANUIK JT et al.: Cold- and cryopreservation of human liver and kidney slices. Cryobiology (1993) 30(3):250-261.
  • OLINGA P, MEREMA MT, HOF IH et al.: Effect of cold and warm ischaemia on drug metabolism in isolated hepatocytes and slices from human and monkey liver. Xenobiotica (1998) 28(4):349-360.
  • HEWITT NJ, DE KANTER R, LECLUYSE E: Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry – do they comply with FDA recommendations? Chem. Biol. Interact. (2007) 168(1):51-65.
  • MAZUR P: Freezing of living cells: mechanisms and implications. Am. J. Physiol. (1984) 247(3 Part 1):C125-C142.
  • DE GRAAF IA, KOSTER HJ: Cryopreservation of precision-cut tissue slices for application in drug metabolism research. Toxicol. In Vitro (2003) 17(1):1-17.
  • BISCHOF JC, RYAN CM, TOMPKINS RG, YARMUSH ML, TONER M: Ice formation in isolated human hepatocytes and human liver tissue. Asaio J. (1997) 43(4):271-278.
  • PEGG D, DIAPER MP: Freezing versus vitrification: Basic Principles. In: Cryopreservation and Low Temperature Biology in Blood Transfusion. Smit Sibenga CT, Das PT, Meryman HT (Eds), Kluwer Academic Press, Dordrecht, The Netherlands (1990):55-69.
  • MAAS WJ, DE GRAAF IA, SCHOEN ED et al.: Assessment of some critical factors in the freezing technique for the cryopreservation of precision-cut rat liver slices. Cryobiology (2000) 40(3):250-263.
  • MAAS WJ, LEEMAN WR, GROTEN JP, VAN DE SANDT JJ: Cryopreservation of precision-cut rat liver slices using a computer-controlled freezer. Toxicol. In Vitro (2000) 14(6):523-530.
  • FISHER R, PUTNAM CW, KOEP LJ et al.: Cryopreservation of pig and human liver slices. Cryobiology (1991) 28(2):131-142.
  • RYPKA M, CERVENKOVA K, UHERKOVA L et al.: A novel simplified ultra-rapid freezing technique for cryopreservation of tissue slices. Cryobiology (2006) 52(2):193-199.
  • DE GRAAF IA, KOSTER HJ: Water crystallization within rat precision-cut liver slices in relation to their viability. Cryobiology (2001) 43(3):224-237.
  • GLOCKNER R, ROST M, PISSOWOTZKI K, MULLER D: Monooxygenation, conjugation and other functions in cryopreserved rat liver slices until 24 h after thawing. Toxicology (2001) 161(1-2):103-109.
  • DAY SH, NICOLL-GRIFFITH DA, SILVA JM: Cryopreservation of rat and human liver slices by rapid freezing. Cryobiology (1999) 38(2):154-159.
  • VANHULLE VP, NEYRINCK AM, PYCKE JM, HORSMANS Y, DELZENNE NM: Role of apoptotic signaling pathway in metabolic disturbances occurring in liver tissue after cryopreservation: study on rat precision-cut liver slices. Life Sci. (2006) 78(14):1570-1577.
  • FAHY GM, ALI SE: Cryopreservation of the mammalian kidney. II. Demonstration of immediate ex vivo function after introduction and removal of 7.5 M cryoprotectant. Cryobiology (1997) 35(2):114-131.
  • FAHY GM, WOWK B, WU J, PAYNTER S: Improved vitrification solutions based on the predictability of vitrification solution toxicity. Cryobiology (2004) 48(1):22-35.
  • CONNORS MS, LARRAURI A, DANNECKER R et al.: Biotransformation of a somatostatin analogue in precision-cut liver and kidney slices from rat, dog and man. Xenobiotica (1996) 26(2):133-141.
  • VICKERS AE, FISCHER V, CONNORS MS et al.: Biotransformation of the antiemetic 5-HT3 antagonist tropisetron in liver and kidney slices of human, rat and dog with a comparison to in vivo. Eur. J. Drug Metab. Pharmacokinet. (1996) 21(1):43-50.
  • VICKERS AE, FISCHER V, CONNORS S et al.: Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines. Drug Metab. Dispos. (1992) 20(6):802-809.
  • VICKERS AE, FISHER RL, BRENDEL K et al.: Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin A metabolism. Drug Metab. Dispos. (1995) 23(3):327-333.
  • VICKERS AE, JIMENEZ RM, SPAANS MC et al.: Human and rat lung biotransformation of cyclosporin A and its derivatives using slices and bronchial epithelial cells. Drug Metab. Dispos. (1997) 25(7):873-880.
  • VICKERS AEM, ZOLLINGER M, DANNECKER R et al.: In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions. Drug Metab. Dispos. (2001) 29(10):1269-1276.
  • NEMERY B, ALDRIDGE WN: Studies on the metabolism of the pneumotoxin O,S,S-trimethyl phosphorodithioate-II. Lung and liver slices. Biochem. Pharmacol. (1988) 37(19):3717-3722.
  • KRETZ O, GUENAT C, BEILSTEIN P, GROSS G: Coincubation of tissue slices, a new way to study metabolic cooperation between organs: hepatorenal cooperation in the biotransformation of CGP 47 969 A. J. Pharmacol. Toxicol. Methods (2002) 48(2):119-126.
  • VON RICHTER O, GREINER B, FROMM MF et al.: Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique. Clin. Pharmacol. Ther. (2001) 70(3):217-227.
  • GLAESER H, DRESCHER S, HOFMANN U et al.: Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humans. Clin. Pharmacol. Ther. (2004) 76(3):230-238.
  • KOLARS JC, AWNI WM, MERION RM, WATKINS PB: First-pass metabolism of cyclosporin by the gut. Lancet (1991) 338(8781):1488-1490.
  • BARTER ZE, BAYLISS MK, BEAUNE PH et al.: Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr. Drug Metab. (2007) 8(1):33-45.
  • WORBOYS PD, BRADBURY A, HOUSTON JB: Kinetics of drug metabolism in rat liver slices. Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds. Drug Metab. Dispos. (1995) 23(3):393-397.
  • EKINS S, MURRAY GI, BURKE MD et al.: Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug Metab. Dispos. (1995) 23(11):1274-1279.
  • HANSEN T, BORLAK J, BADER A: Cytochrome P450 enzyme activity and protein expression in primary porcine enterocyte and hepatocyte cultures. Xenobiotica (2000) 30(1):27-46.
  • LAKE BG, BEAMAND JA, JAPENGA AC et al.: Induction of cytochrome P-450-dependent enzyme activities in cultured rat liver slices. Food Chem. Toxicol. (1993) 31(5):377-386.
  • GLOCKNER R, MULLER D: Ethoxycoumarin O-deethylation (ECOD) activity in rat liver slices exposed to β-naphthoflavone (BNF) in vitro. Exp. Toxicol. Pathol. (1995) 47(4):319-324.
  • DRAHUSHUK AT, MCGARRIGLE BP, TAI HL et al.: Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicol. Appl. Pharmacol. (1996) 140(2):393-403.
  • MULLER D, GLOCKNER R, ROST M: Monooxygenation, cytochrome P4501A1 and P4501A1-mRNA in rat liver slices exposed to β-naphthoflavone and dexamethasone in vitro. Exp. Toxicol. Pathol. (1996) 48(5):433-438.
  • LAKE BG, CHARZAT C, TREDGER JM et al.: Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices. Xenobiotica (1996) 26(3):297-306.
  • GOKHALE MS, BUNTON TE, ZURLO J, YAGER JD: Cytochrome P450 isoenzyme activities in cultured rat and mouse liver slices. Xenobiotica (1997) 27(4):341-355.
  • NEUPERT G, GLOCKNER R, MULLER D: Immunohistochemical localization of cytochrome P450 1A1 in precision-cut rat liver slices after in vitro exposure to β-naphthoflavone. Exp. Toxicol. Pathol. (1998) 50(4-6):514-518.
  • PARRISH AR, FISHER R, BRAL CM et al.: Benzo(a)pyrene-induced alterations in growth-related gene expression and signaling in precision-cut adult rat liver and kidney slices. Toxicol. Appl. Pharmacol. (1998) 152(2):302-308.
  • KUHN UD, SPLINTER FK, ROST M, MULLER D: Induction of cytochrome P450 1A1 in rat liver slices by 7-ethoxycoumarin and 4-methyl-7-ethoxycoumarin. Exp. Toxicol. Pathol. (1998) 50(4-6):491-496.
  • DRAHUSHUK AT, MCGARRIGLE BP, SLEZAK BP, STEGEMAN JJ, OLSON JR: Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. (1999) 155(2):127-138.
  • LAKE BG, BEAMAND JA, TREDGER JM et al.: Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. Mutat. Res. (1999) 440(1):91-100.
  • PAN J, XIANG Q, RENWICK AB et al.: Use of a quantitative real-time reverse transcription-polymerase chain reaction method to study the induction of CYP1A, CYP2B and CYP4A forms in precision-cut rat liver slices. Xenobiotica (2002) 32(9):739-747.
  • MEREDITH C, SCOTT MP, RENWICK AB, PRICE RJ, LAKE BG: Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica (2003) 33(5):511-527.
  • PRICE RJ, RENWICK AB, WALTERS DG, YOUNG PJ, LAKE BG: Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicol. In Vitro (2004) 18(2):179-185.
  • PUSHPARAJAH DS, UMACHANDRAN M, PLANT KE, PLANT N, IOANNIDES C: Evaluation of the precision-cut liver and lung slice systems for the study of induction of CYP1, epoxide hydrolase and glutathione S-transferase activities. Toxicology (2007) 231(1):68-80.
  • MULLER D, STEINMETZER P, PISSOWOTZKI K, GLOCKNER R: Induction of cytochrome P450 2B1-mRNA and pentoxyresorufin O-depentylation after exposure of precision-cut rat liver slices to phenobarbital. Toxicology (2000) 144(1-3):93-97.
  • CUI X, THOMAS A, HAN Y et al.: Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo. J. Pharmacol. Toxicol. Methods (2005) 52(2):234-243.
  • CATANIA JR, MCGARRIGLE BP, RITTENHOUSE-OLSON K, OLSON JR: Induction of CYP2B and CYP2E1 in precision-cut rat liver slices cultured in defined medium. Toxicol. In Vitro (2007) 21(1):109-115.
  • GLOCKNER R, WAGENER J, LIEDER A, MULLER D: In vitro induction of cytochrome P4503A1-mRNA and testosterone hydroxylation in precision-cut liver slices from male and female rats. Exp. Toxicol. Pathol. (2003) 54(5-6):411-415.
  • WAUTHIER V, VERBEECK RK, BUC CALDERON P: The use of precision-cut liver slices from male Wistar rats as a tool to study age related changes in CYP3A induction and in formation of paracetamol conjugates. Toxicol. In Vitro (2004) 18(6):879-885.
  • LAKE BG, BALL SE, RENWICK AB et al.: Induction of CYP3A isoforms in cultured precision-cut human liver slices. Xenobiotica (1997) 27(11):1165-1173.
  • DRAHUSHUK AT, MCGARRIGLE BP, LARSEN KE, STEGEMAN JJ, OLSON JR: Detection of CYP1A1 protein in human liver and induction by TCDD in precision-cut liver slices incubated in dynamic organ culture. Carcinogenesis (1998) 19(8):1361-1368.
  • GLOCKNER R, STEINMETZER P, DROBNER C, MULLER D: Application of cryopreserved precision-cut liver slices in pharmacotoxicology – principles, literature data and own investigations with special reference to CYP1A1-mRNA induction. Exp. Toxicol. Pathol. (1998) 50(4-6):440-449.
  • LAKE BG, TREDGER JM, RENWICK AB, BARTON PT, PRICE RJ: 3,3′-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices. Xenobiotica (1998) 28(8):803-811.
  • EDWARDS RJ, PRICE RJ, WATTS PS et al.: Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab. Dispos. (2003) 31(3):282-288.
  • LAKE BG, MEREDITH C, SCOTT MP, RENWICK AB, PRICE RJ: Use of cultured precision-cut rat lung slices to study the in vitro induction of pulmonary cytochrome P450 forms. Xenobiotica (2003) 33(7):691-702.
  • MARTIGNONI M, GROOTHUIS G, DE KANTER R: Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab. Dispos. (2006) 34(6):1047-1054.
  • RENWICK AB, BALL SE, TREDGER JM et al.: Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices. Xenobiotica (2002) 32(10):849-862.
  • LAKE BG, BALL SE, KAO J et al.: Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase. Xenobiotica (2002) 32(10):835-847.
  • PISANI F, PERUCCA E, PRIMERANO G et al.: Single-dose kinetics of primidone in acute viral hepatitis. Eur. J. Clin. Pharmacol. (1984) 27(4):465-469.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.